The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

Participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 milligrams, or Wegovy, 1.7 milligrams or 2.4 milligrams. By the end of the trial ...

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday its chief executive was stepping down in the wake of "market challenges".

The company announced the detailed results from SURMOUNT-5, a Phase 3b open-label clinical trial ... reduction of 7.2 in (18.4 cm), while those treated with Wegovy saw an average reduction ...

The first head-to-head trial of two blockbuster weight-loss drugs has shown Mounjaro is more effective than rival Wegovy. Both drugs led to substantial weight loss, but Mounjaro's 20% weight ...